visual of neurons under Parkinsons disease
Marketing

AbbVie pumps up the case for early subcutaneous Parkinson’s care

Delaying the use of subcutaneous Parkinson’s disease treatments by one year increases annual medical costs by 59.1%, AbbVie-sponsored research found.
Nick Paul Taylor Oct 22, 2026 6:32am
Podcast
The Next Chapter for AI in Clinical Trials

The Next Chapter for AI in Clinical Trials

Brought to you by Saama
Otsuka

Otsuka hit with marketing breaches after event organizer blunder

Oct 22, 2026 2:23am
Why Are 53 of Phase 2 and 3 Trials Delayed A Redesign Is Overdue

Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue

Brought to you by Bain & Company
direct to consumer DTC online shopping

Direct-to-patient pharma programs transform drug access: survey

Oct 21, 2026 1:24pm
eye with dollar sign

Alcon acquires Neurotech and its approved Encelto for $550M

Oct 21, 2026 10:56am
More News

ICER, West Health call out excessive U.S. drug launch prices

Oct 21, 2026 10:36am

CSL taps GSK’s Deborah Waterhouse as CEO in darkest hour

Oct 21, 2026 10:22am

GSK wins groundbreaking FDA green light in chronic hepatitis B

Oct 21, 2026 6:39am

FDA finalizes guidance on prescription drug apps

Oct 20, 2026 5:59pm